Skip to main content

Advertisement

Log in

Ectopic Duodenal Insulinoma: A Very Rare and Challenging Tumor Type. Description of a Case and Review of the Literature

  • Published:
Endocrine Pathology Aims and scope Submit manuscript

Abstract

Although most insulinomas are located in the pancreas, very rare ectopic cases have been described in the spleen, perisplenic tissue, duodenohepatic ligament, and adjacent to the ligament of Treitz. Moreover, three cases located in the duodenum have also been reported in the English literature. Ectopic insulinomas represent challenging neoplasms with clinical implications mainly due to the difficulties in their pre-operatory diagnosis and localization. In the present paper, we describe the fourth ectopic duodenal insulinoma so far reported. A 75-year-old woman presented at clinical observation due to neuroglycopenic symptoms that disappeared after glucose intake. Tumor was localized in the second portion of the duodenum in front of the papilla of Vater and was surgically enucleated. Microscopically, it was composed of monomorphic cells with eosinophilic cytoplasm arranged in trabecular and lobular patterns and diffusely positive for insulin, proinsulin, amylin, and PDX1. About 30 % of tumor cells also showed immunoreactivity for somatostatin, while no positivity for glucagon, pancreatic polypeptide, gastrin, serotonin, and somatostatin receptor subtype 2A was found. The Ki67 proliferative index was 1 %. We have also reviewed the literature on this topic to give the reader a comprehensive overview of this very rare tumor type.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Capella C, Arnold R, Klimstra DS, et al. (2010) Neuroendocrine neoplasms of the small intestine. In: Bosman, FT, Carneiro F, Hruban RH, Theise ND (eds.) WHO classification of tumors of the digestive system. IARC Press, Lyon, pp 102–107.

    Google Scholar 

  2. Soga J (2003) Endocrinocarcinomas (carcinoids and their variants) of the duodenum. An evaluation of 927 cases. J Exp Clin Cancer Res 22:349–363.

    PubMed  CAS  Google Scholar 

  3. Lawrence B, Gustafsson BI, Chan A, Svejda B, Kidd M, Modlin IM (2011) The epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin N Am 40:1–18.

    Article  Google Scholar 

  4. Capella C, Riva C, Rindi G, et al. (1991) Histopathology, hormone products, and clinicopathological profile of endocrine tumor of the upper small intestine: a study of 44 cases. Endocr Pathol 2:92–110.

    Article  Google Scholar 

  5. Karasawa Y, Sakaguchi M, Minami S, et al. (2001) Duodenal somatostatinoma and erythrocytosis in a patients with von Hippel–Lindau disease type 2A. Inter Med 40:38–43.

    Article  CAS  Google Scholar 

  6. Komminoth P, Perren A, Öberg K, Rindi G, Heitz PU, Klöppel G. (2004) Insulinoma. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) WHO classification of tumors of endocrine organs. IARC Press, Lyon, pp 183–186.

    Google Scholar 

  7. Stefanini P, Carboni M, Patrassi N, Basoli A (1974) Beta-islet cell tumors of the pancreas: results of a study on 1,067 cases. Surgery 75:597–609.

    PubMed  CAS  Google Scholar 

  8. Cárdenas CM, Domínguez I, Campuzano M, et al. (2009) Malignant insulinoma arising from intrasplenic heterotopic pancreas. JOP 10:321–323.

    PubMed  Google Scholar 

  9. Yoshikawa K, Wakasa H (1980) Hypoglycemia associated with aberrant insulinoma: a case report of 16 years follow-up. Tohoku J Exp Med 132:17–29.

    Article  PubMed  CAS  Google Scholar 

  10. Xiang-Ling W, Yi-Ming M, Jing-Tao D, Wen-Wen Z, Zhao-Hui L, Ju-Ming L (2011) Successful laparoscope resection of ectopic insulinoma in duodenohepatic ligament. Am J Med Sci 341:420–422.

    Article  Google Scholar 

  11. Hennings J, Garske U, Botling J, Hellman P (2005) Malignant insulinoma in ectopic pancreatic tissue. Dig Surg 22:377–379.

    Article  PubMed  Google Scholar 

  12. Watanabe W, Kurumada T, Shirai T, Tsutsumi Y (1995) Aberrant insulinoma of the duodenal bulb. Pathol Int 45:895–900.

    Article  PubMed  CAS  Google Scholar 

  13. Miyazaki K, Funakoshi A, Nishihara S, Wasada T, Koga A, Ibayashi H (1986) Aberrant insulinoma in the duodenum. Gastroenterology 90:1280–1285.

    PubMed  CAS  Google Scholar 

  14. Tolentino LF, Lee H, Maung T, Stabile BE, Li K, French SW (2004) Islet cell tumor arising from a heterotopic pancreas in the duodenal wall with ulceration. Exp Mol Pathol 76:51–56.

    Article  PubMed  CAS  Google Scholar 

  15. Rindi G, Arnold R, Bosman FT, et al. (2010) Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In: Bosman, FT, Carneiro F, Hruban RH, Theise ND (eds.) WHO classification of tumors of the digestive system. 2010 IARC Press, Lyon, 13–14.

    Google Scholar 

  16. Solcia E, Kloppel G, Sobin LH (2000) Histological typing of endocrine tumors. 2nd edn. Springer-Verlag, Berlin

    Book  Google Scholar 

  17. Rindi G, Falconi M, Klersy C, et al. (2012) TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. J Natl Cancer Inst 104:764–777.

    Article  PubMed  CAS  Google Scholar 

  18. La Rosa S, Furlan D, Sessa F, Capella C (2010) The endocrine pancreas. In: Lloyd RV (ed) Differential diagnosis and molecular advances, 2nd edn. Springer, New York, pp 367–413

    Google Scholar 

  19. Lukinius A, Wilander E, Westermark GT, Engström U, Westermark P (1989) Co-localization of islet amyloid polypeptide and insulin in the B-cell secretory granules of the human pancreatic islets. Diabetologia 32:240–244.

    Article  PubMed  CAS  Google Scholar 

  20. Srivastava A, Hornick JL (2009) Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors. Am J Surg Pathol 33:626–632.

    Article  PubMed  Google Scholar 

  21. Deshpande V, Fernandez-del Castillo C, Muzikansky A, et al. (2004) Cytokeratin 19 is a powerful predictor of survival in pancreatic endocrine tumors. Am J Surg Pathol 28:1145–1153.

    Article  PubMed  Google Scholar 

  22. La Rosa S, Rigoli E, Uccella S, Novario R, Capella C (2007) Prognostic and biological significance of cytokeratin 19 in pancreatic endocrine tumors. Histopathology 50:597–606.

    Article  PubMed  Google Scholar 

  23. Portela-Gomes GM, Stridsberg M, Grinelius L, Rorstad O, Janson ET (2007) Differential expression of the somatostatin receptor subtypes in human benign and malignant insulinomas—predominance of receptor subtype 4. Endocr Pathol 18:79–85.

    Article  PubMed  CAS  Google Scholar 

  24. Smith FG, Ohio M (1942) Aberrant pancreatic tissue with hyperinsulinism. JAMA 118:454–455.

    Article  Google Scholar 

  25. Roggli VL, Judge DM, McGavran MH (1979) Duodenal glucagonoma: a case report. Hum Pathol 10:350–353.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stefano La Rosa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

La Rosa, S., Pariani, D., Calandra, C. et al. Ectopic Duodenal Insulinoma: A Very Rare and Challenging Tumor Type. Description of a Case and Review of the Literature. Endocr Pathol 24, 213–219 (2013). https://doi.org/10.1007/s12022-013-9262-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12022-013-9262-y

Keywords

Navigation